REYON Pharmaceutical Co., Ltd. (KRX:102460)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical			151.07B	154.04B	142.80B	130.03B	-
Pharmaceutical Growth			-1.93%	7.87%	9.82%	-	-
Pharmaceuticals Manufacturing and Sales			-	-	-	-	131.56B
Pharmaceuticals Manufacturing and Sales Growth			-	-	-	-	6.97%
Total			151.07B	154.04B	142.80B	130.03B	131.56B
Total Growth			-1.93%	7.87%	9.82%	-1.16%	6.97%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Other			75.42M	-	-	3.76M	12.72M
Other Growth			-	-	-	-70.44%	-
Vietnam			446.77M	323.36M	-	65.05M	160.21M
Vietnam Growth			38.17%	-	-	-59.40%	-
Thailand			32.70M	-	-	-	-
Mongolia			60.96M	31.69M	47.42M	44.13M	23.72M
Mongolia Growth			92.36%	-33.17%	7.45%	86.09%	-
Republic of Korea			149.52B	151.67B	140.89B	128.02B	127.69B
Republic of Korea Growth			-1.42%	7.65%	10.05%	0.26%	-
Japan			831.00M	1.79B	1.78B	1.85B	1.81B
Japan Growth			-53.46%	0.51%	-3.95%	2.42%	-
Georgia			-	18.33M	5.57M	-	-
Georgia Growth			-	228.87%	-	-	-
Malaysia			-	-	8.95M	-	-
Peru			89.26M	-	69.28M	46.78M	130.72M
Peru Growth			-	-	48.09%	-64.21%	-
Hong Kong			17.14M	17.60M	-	-	-
Hong Kong Growth			-2.63%	-	-	-	-
Indonesia			-	197.06M	-	-	-
India			-	-	-	-	1.73B
Total			151.07B	154.04B	142.80B	130.03B	131.56B
Total Growth			-1.93%	7.87%	9.82%	-1.16%	-

Source: S&P Global Market Intelligence.